Loading clinical trials...

L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder | Clinical Trials | Clareo Health

WITHDRAWNPhase 2NCT02139761

L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder

Cocaine continues to be one of the most widely used substances of abuse around the world. In the US, an estimated 1.4 million individuals (0.5%) \> 12 years were current (past month) cocaine users in ...

Lead sponsor: University of Maryland, Baltimore•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Repurposing Semaglutide for the Treatment of Cocaine Use Disorder

NCT07227948 · Cocaine Use Disorder

RECRUITINGNA

Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder

NCT07071779 · Alcohol Use Disorder (AUD), Cocaine Use Disorder (CUD), and more

RECRUITINGNA

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

NCT04927143 · Opioid-use Disorder, Cocaine Use Disorder, and more

RECRUITINGNA

A Trial Of Approach Bias Modification Training During Treatment For Cocaine Use Disorder

NCT07033416 · Training for Cocaine Use Disorder

RECRUITING

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study

NCT04721418 · Cocaine Use Disorder, Healthy Controls

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 4, 2019Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE2

Enrollment—

Start dateSep 2014

Last updatedNov 4, 2019

Condition

Cocaine Use

Locations shown

Maryland Psychiatric Research Center

Catonsville, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 4, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Repurposing Semaglutide for the Treatment of Cocaine Use Disorder

Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

A Trial Of Approach Bias Modification Training During Treatment For Cocaine Use Disorder

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study

Trial snapshot

Condition

Locations shown

For caregivers